In a notable shift in sentiment, Mark Altschwager from Baird has downgraded Bath & Body Works, Inc. (BBWI) to a Neutral rating as of November 21, 2025. This adjustment comes as the company navigates a challenging retail environment characterized by volatile consumer behavior and financial performance that has recently missed analysts’ expectations. For investors, this rating change may signal caution as BBWI attempts to find stability in a fluctuating market.
Recent Price Action
As of the last trading session, Bath & Body Works shares are priced at $14.85. The stock has seen significant volatility, with a 52-week high of $42.12 demonstrating the drastic conditions in which the stock has operated, alongside a low of $3.73. The price has fluctuated recently, recording a change of $0.79, which translates to a 5.32% increase. Trading volume stood at approximately 6.41 million, slightly below the three-month average of 7.77 million, indicating varied investor interest as the stock attempts to regain its footing in the marketplace. The current market capitalization of $3.30 billion positions BBWI within a competitive space, while a beta of 1.449 suggests the stock is subject to higher volatility compared to broader market movements.
Short- and Long-Term Performance
Examining Bath & Body Works’ performance paints a more complex picture. Over the last 30 days, the stock has declined by 11.06%, reflecting broader retail pressures and perhaps a waning consumer demand. In the last 90 days, the stock’s performance has been even more troubling, with an 18.06% drop. The year-to-date perspective reveals a staggering decline of 26.76%. This compounded performance, alongside a weekly volatility rate of 4.46% and monthly volatility of 3.71%, suggests that investors have been navigating a particularly choppy trading environment. Increased volatility is often a sign of uncertainty in how the market perceives the company’s future growth potential.
Earnings Analysis
In its latest earnings report, released on November 20, 2025, Bath & Body Works reported earnings per share (EPS) of $0.35, which fell short of the projected estimate of $0.40, marking a negative surprise of approximately 12.5%. This deviation from expectations, while modest, adds to the concerns surrounding the company’s financial predictability. In the previous quarter, EPS matched the estimate at $0.37, indicating a potential inconsistency in earnings performance. Such misses can lead to diminished investor confidence, particularly in a retail environment already burdened by economic pressures.
Analyst / Consensus View
The broader analyst community appears divided on Bath & Body Works. The recent consensus consists of 18 ratings, equally split between nine Buy and nine Hold opinions, with no Sell ratings reported. The average price target among analysts stands at $28.25, significantly above the current price, with a high target reaching $43 and a low of $17. The recent downgrade to Neutral by Baird’s Mark Altschwager, which included a price target of $19, suggests a cautiousness amid uncertainty, highlighting that while there is potential for upward movement, risks remain palpable.
Stock Grading or Fundamental View
Bath & Body Works has received a Stocks Telegraph Score of 47, indicating mediocrity in its overall health and investment profile. This score reflects several underlying financial challenges and market dynamics that investors should consider. A score around this range signals that while there are areas of strength, there are also notable weaknesses that merit careful scrutiny. Investors looking at BBWI should weigh its operational effectiveness and market strategies against an uncertain retail backdrop.
Conclusion
As the retail landscape evolves, investors will need to approach Bath & Body Works with a balanced perspective. This stock may suit those with a defensive or value-oriented investment philosophy, recognizing the current discounts against potential upside. However, risks related to earnings performance, high volatility, and market sentiment warrant caution. As such, BBWI may be worth monitoring closely for signs of recovery, particularly if the company can leverage its strong brand presence to entice a recovering consumer base. The evolving circumstances surrounding BBWI suggest both opportunity and risk as it navigates the complexities of the current market environment.